# Appendix Table 1. Basic Fields | Field | Category | Description | |--------------------|----------------------|-----------------------------------------------------------------------------| | pubmed_id | data_source | PubMed identifier of the reference | | reference_name | data_source | Title or short name of the reference | | patient_id | sample_information | Internal de-identified patient identifier | | tumor_tissue | sample_information | Tumor sample tissue | | tumor_type_detail | sample_information | Original tumor type name reported in literature | | gene | mutation_information | Gene symbol | | mutation_type | mutation_information | Mutation class | | mutation | mutation_information | Mutation description (HGVS format or amino acid change, e.g., p.G12D) | | position | mutation_information | Mutation position within the peptide sequence (relative position in peptide)| | chromosome | mutation_information | Chromosome number (1–22, X, Y) | | genomic_coord | mutation_information | Genomic coordinate | | ref | mutation_information | Reference allele | | alt | mutation_information | Alternative allele | | mt_peptide | peptide_information | Mutated peptide (8–14mer) | | wt_peptide | peptide_information | Corresponding wild-type peptide | | length | peptide_information | Peptide length | | hla | peptide_information | Restricting HLA allele | | response_type | peptide_information | Response category | | assay_type | assay_information | Immunological assay type, harmonized from original literature into standardized categories. Multiple assay types may apply. | | effector_origin | assay_information | Source of effector T cells as described in the original study | | stimulation_target | assay_information | The target used to stimulate T cells, summarized from experimental description | | presentation_method| assay_information | Experimental method used to demonstrate peptide presentation |